Drug intelligence / Profile preview

bromovulone III

Development stage
Preclinical
Modality
Small Molecules
01

Overview

Bromovulone III is a marine prostanoid isolated from the soft coral *Clavularia viridis*. It exhibits potent anti-tumor activity against various malignancies, including hepatocellular carcinoma (HCC), prostate cancer, and acute promyelocytic leukemia. The compound induces apoptotic cell death through a dual mechanism involving endoplasmic reticulum (ER) stress and mitochondrial dysfunction. In hepatocellular carcinoma cells (such as Hep3B), bromovulone III primarily triggers the activation of m-calpain, caspase-12, and the transcription factor CHOP/GADD153, leading to ER stress-mediated apoptosis. In other tumor types like PC-3 and HL-60, it primarily activates the intrinsic mitochondrial pathway involving caspase-9 and caspase-3. The crosstalk between ER stress and mitochondrial depolarization further enhances its cytotoxic effects.

Other names
bromovulone III
02

Targets

CASP3 (Caspase-3)DDIT3 (DNA damage-inducible transcript 3 protein)CAPN (Schistosoma calpain large subunit family)TNFR (TNF receptor family)CASP12 (Caspase-12)CASP9 (Caspase-9)

Beyond the preview

Go deeper on bromovulone III.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bromovulone III.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call